Search Results 1291-1300 of 17502 for Absence

  1. EndovaSCularTreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial) - Mayo Clinic

    ... absence of collaterals in the affected territory on the delayed phases of the mCTA; OR. 9b. NCCT + (m)CTA/spCTA ± CTP** Lack of core:penumbra mismatch (if ...

  2. Publications - Kevin O. Leslie, M.D. - Mayo Clinic

    Depressed unloaded sarcomere shortening velocity in acute murine coxsackievirus myocarditis: myocardial remodeling in the absence of necrosis or hypertrophy.

  3. A Study Comparing 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR to Treat Patients with Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours - Mayo Clinic

    ... absence of effective, non-hormonal means of contraception (intrauterine contraceptive device, barrier method of contraception in conjunction with ...

  4. Publications - TK A. Kile, M.D. - Mayo Clinic

    "Absent middle facet": a sign on unenhanced radiography of subtalar joint coalition. AJR Am J Roentgenol. 2003 Dec; 181: (6)1565-72. View PubMed; Senall JA ...

  5. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    ... absence of other renal cell carcinoma subtype or urothelial carcinoma);; Bone only urothelial carcinoma or other non-prostate GU tumor;; Urethra carcinoma ...

  6. Idiopathic Erythrocytosis Impact on Patient Well-Being - Mayo Clinic

    Patients diagnosed with idiopathic erythrocytosis, defined as Hemoglobin > 16.5 g/dL men, > 16 g/dL women or hematocrit > 49% men, > 48% women, absence of ...

  7. Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors - Mayo Clinic

    Postmenopausal, defined as continuous absence of menstruation for 12 months OR status-post bilateral oophorectomy OR follicle stimulating hormone (FSH) level in ...

  8. Publications - Ruth Lupu, Ph.D. - Mayo Clinic

    Trastuzumab in combination with heregulin-activated Her-2 (erbB-2) triggers a receptor-enhanced chemosensitivity effect in the absence of Her-2 overexpression.

  9. Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular Age-related Macular Degeneration (PANDA-1) - Mayo Clinic

    Have aphakia or pseudophakia with absence of posterior capsule (unless it occurred as a result of yttrium aluminum garnet (YAG) posterior capsulotomy) in the ...

  10. Mayo Clinic School of Medicine Archives

    took a one-year leave of absence from medical school to get a master's in public health from Columbia University. She hopes to incorporate the new ...